A carregar...
LOW GLUCOSE ENHANCES METFORMIN PROTECTION EFFICIENCY AGAINST DOXORUBICIN INDUCED CYTOTOXICITY
The anti-diabetic drug, metformin, has been reported to benefit the cardiovascular system and may facilitate extension of healthy lifespan. Doxorubicin (doxo) is a leading chemotherapeutic drug used to treat a variety of cancers, but it has cardiotoxic effects that limit its clinical benefit. To tes...
Na minha lista:
| Publicado no: | Innov Aging |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6239411/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/geroni/igy031.3300 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|